The latest lymphoma news
CNIO researchers discover a new pathway to tackle follicular lymphoma
For their own benefit and to grow beyond control, tumours manipulate cell signals to make…
The latest lymphoma news
For their own benefit and to grow beyond control, tumours manipulate cell signals to make…
A new class of drugs that inhibits a “master switch” involved in the vast majority…
DESCAR-T is the French national registry for patients treated with commercial chimeric antigen receptor (CAR)-T…
Many early-stage patients with bulky classic Hodgkin lymphoma (cHL) can avoid radiotherapy treatment and still…
Preclinical study supports clinical trial of cord blood-derived natural killer cells with Affimed’s AFM13 as…
Researchers have found a long-sought enzyme that prevents cancer by enabling the breakdown of proteins…
Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led…
A combination of copanlisib and rituximab led to a 48 percent reduction in the risk…
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to…
Mantle cell lymphoma is a malignant disease in which intensive treatment can prolong life. In…